New drug-related controversy in the Picks or Depakine image. This time it is the Androcur that is targeted. Health Insurance and the National Agency for the Safety of Medicines and Health Products (ANSM), the
in France, sent together a mail for more than 80,000 patients, 30,000 private doctors and 2,000 health units to warn about the risks of meningioma.
«You are welcome to consult your doctor»
Androcur and its generics are mainly used to treat certain conditions. Originally it was used to combat hyperpilosity or treatment of prostate cancer, but it was also used as a contraceptive pill, anti-acne or as a cure for endometriosis and polycystic ovarian syndrome. .
" The risk of these brain tumors, most often non-cancerous, is multiplied by seven plus six months of treatment, and twenty times prolonged and high doses!
"You are welcome to consult your doctor," it is written in bold in the letter.
A form to sign
Alain-Michel Ceretti, head of France Assos Santé, a federation of users says
that as of July 1, doctors prescribing Androcur will be required to have their patients sign a form
informing them of the risks
. " Your doctor will need to tell you whether the medicine is given in or out of the Marketing Authorization (MA). It was also clear that this certificate is by no means a release of responsibility. The opposite would be the height ", Continues Ceretti.